Indivior PLC (NASDAQ:INDV) Shares Acquired by Man Group plc

Man Group plc lifted its position in shares of Indivior PLC (NASDAQ:INDV - Free Report) by 291.3% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 45,365 shares of the company's stock after purchasing an additional 33,771 shares during the period. Man Group plc's holdings in Indivior were worth $564,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also bought and sold shares of the business. Deerfield Management Company L.P. Series C raised its position in shares of Indivior by 74.4% in the fourth quarter. Deerfield Management Company L.P. Series C now owns 8,883,160 shares of the company's stock valued at $110,418,000 after purchasing an additional 3,790,518 shares during the period. Newtyn Management LLC raised its holdings in shares of Indivior by 62.0% during the 4th quarter. Newtyn Management LLC now owns 1,406,531 shares of the company's stock valued at $17,483,000 after buying an additional 538,426 shares in the last quarter. Millennium Management LLC grew its holdings in shares of Indivior by 36.9% during the 4th quarter. Millennium Management LLC now owns 1,233,006 shares of the company's stock valued at $15,326,000 after purchasing an additional 332,180 shares during the last quarter. Ardsley Advisory Partners LP lifted its stake in shares of Indivior by 11.0% in the 4th quarter. Ardsley Advisory Partners LP now owns 1,200,000 shares of the company's stock valued at $14,916,000 after acquiring an additional 119,050 shares during the last quarter. Finally, CenterBook Partners LP grew its holdings in shares of Indivior by 105.5% in the fourth quarter. CenterBook Partners LP now owns 1,147,841 shares of the company's stock worth $14,268,000 after purchasing an additional 589,158 shares during the last quarter. Hedge funds and other institutional investors own 60.33% of the company's stock.

Indivior Stock Performance

Shares of INDV traded up $0.28 during mid-day trading on Friday, reaching $12.69. The stock had a trading volume of 291,821 shares, compared to its average volume of 1,203,296. The business has a fifty day moving average of $10.43 and a 200 day moving average of $10.74. The firm has a market cap of $1.75 billion, a price-to-earnings ratio of -36.31 and a beta of 0.98. Indivior PLC has a 12 month low of $7.33 and a 12 month high of $18.59.

Indivior (NASDAQ:INDV - Get Free Report) last announced its quarterly earnings results on Thursday, April 24th. The company reported $0.41 earnings per share for the quarter, topping the consensus estimate of $0.22 by $0.19. The company had revenue of $266.00 million for the quarter, compared to analysts' expectations of $240.13 million. Indivior had a negative net margin of 3.96% and a negative return on equity of 241.73%. On average, research analysts forecast that Indivior PLC will post 1.22 EPS for the current fiscal year.

Analyst Ratings Changes

Separately, Piper Sandler dropped their price target on Indivior from $16.00 to $13.00 and set an "overweight" rating for the company in a research note on Thursday, March 6th.

Indivior Company Profile

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.